Ads
related to: biogen's- Locations
State-of-the-art drug manufacturing
facilities and expertise. UK & US.
- Experts
Our experts are on hand to help you
solve drug development challenges.
- Contact
Contact our experts about your
drug development programs & needs
- Formulation Optimization
Rapid drug product optimization
Integrated to accelerate timelines
- Accelerate Your Program
Use Translational Pharmaceutics®
to accelerate your drug development
- Events
Meet our experts at global events.
Schedule a meeting with us.
- Locations
Search results
Small Business - Picayune Item | Picayune Item
The Picayune Item· 4 hours agoNEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (Nasdaq: BIIB) Securities Class Action Lawsuit. If you invested in Biogen, you are encouraged
European Commission approves Biogen’s QALSODY for ALS treatment
Pharmaceutical Technology via Yahoo Finance· 6 days agoThe European Commission (EC) has granted marketing authorisation for Biogen's QALSODY (tofersen) an...
European Commission grants marketing approval to Biogen's ALS drug
Reuters via Yahoo News· 6 days agoThe approval is based on a 108-patient trial that showed Qalsody reduced levels of a neurofilament...
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a...
Morningstar· 6 days agoGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Biogen Inc. (BIIB) Investors Glancy Prongay & Murray LLP (“GPM ...
Europe Approves Biogen's Tofersen For Adult Patients With Rare Type Of Neurodegenerative Disorder
Benzinga via Yahoo Finance· 5 days agoOn Thursday, the European Commission granted marketing authorization under exceptional circumstances...
Is Biogen Inc (BIIB) Set to Underperform? Analyzing the Factors
Guru Focus· 5 days agoLong-established in the Drug Manufacturers industry, Biogen Inc (BIIB, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth, and valuation ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 4 days agoBragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Biogen Inc. (“Biogen” or the “Company”) ...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 3 days agoCaptioned Gray v. Biogen Inc., No. 24-cv-01444 (D. Colo.), the Biogen class action lawsuit charges Biogen as well as certain of Biogen’s top current and ...
Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody
Zacks via Yahoo Finance· 5 days agoBiogen’s stock was up 2.6% on Thursday in response to Qalsody’s approval in the EU. Biogen’s stock...
Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a...
Morningstar· 6 days agoBiogen Inc. (Nasdaq: BIIB) announced the European Commission (EC) has granted marketing authorization under exceptional circumstances and maintained orphan designation for QALSODY® (tofersen ...
Ad
related to: biogen's
